MEMANTINE-LAPL memantine hydrochloride 20mg film-coated tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

memantine hydrochloride, Quantity: 20 mg (Equivalent: memantine, Qty 16.62 mg)

Available from:

Lupin Australia Pty Limited

INN (International Name):

memantine hydrochloride

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: croscarmellose sodium; purified talc; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide red; macrogol 400

Administration route:

Oral

Units in package:

56 tablets, 42 tablets, 14 tablets, 28 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of the symptoms of moderately severe to severe Alzheimer's disease (See PHARMACOLOGY; PRECAUTIONS).

Product summary:

Visual Identification: Brownish pink coloured, oval shaped, film-coated tablets, debossed with "20" on one side and "scoreline" on the other side which contain Memantine Hydrochloride 20 mg; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2011-11-17

Patient Information leaflet

1
MEMANTINE-LAPL TABLETS
Memantine Hydrochloride
(Lupin Australia Pty. Ltd)
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet contains answers to some common questions about
Memantine-LAPL tablets.
It does not contain all the information that is known about
Memantine-LAPL tablets. It does not
take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risk of you using this
medicine against the benefits he/she expects it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT MEMANTINE-LAPL TABLETS IS USED FOR
Memantine-LAPL tablet is used to treat moderately severe to severe
Alzheimer's disease (AD).
AD can be described as a general decline in all areas of mental
ability. Memantine-LAPL tablet
belongs to a group of medicines called N-methyl-D-aspartate (NMDA)
receptor antagonists.
It is thought to work by protecting NMDA receptors in the brain
against high levels of the chemical
glutamate, which could be the cause of brain degeneration. NMDA
receptors are involved in the
transmission of nerve signals within the brain, e.g. in learning and
memory.
Memantine-LAPL tablets should improve your thinking capacity and your
ability to remember.
Your doctor, however, may prescribe it for another purpose.
2
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR YOU.
This medicine is only available with a doctor's prescription.
Memantine-LAPL tablets are not addictive.
BEFORE YOU TAKE MEMANTINE-LAPL TABLETS
_WHEN YOU MUST NOT TAKE IT _
_ _
DO NOT TAKE MEMANTINE-LAPL TABLETS IF YOU ARE ALLERGIC TO IT OR ANY OF
THE INGREDIENTS LISTED
AT THE END OF THIS LEAFLET.
Symptoms of an allergic reaction may include shortness of breath,
wheezing or difficulty
breathing, swelling of the face, lips, tongue or other parts of the
body, or rash, itching or hives on
the skin.
DO NOT TAKE MEMANTINE-LAPL TABLETS IF YOU HAVE A